Bakul Pharma Private Limited

Produces APIs, intermediates, and specialty chemicals in Gujarat and Mumbai.

1997 | Mumbai, Maharashtra (India) | Active
Last Updated:

Bakul Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.99 M
  • Company Age 27 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 13.50 Cr
  • Satisfied Charges ₹ 33.08 Cr
  • Revenue Growth -0.80%
  • Profit Growth 76.13%
  • Ebitda 89.95%
  • Net Worth 23.54%
  • Total Assets -4.28%

About Bakul Pharma

Bakul Pharma Private Limited (BPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 October 1997 and has a history of 27 years and five months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.

The company currently has active open charges totaling ₹13.50 Cr. The company has closed loans amounting to ₹33.08 Cr, as per Ministry of Corporate Affairs (MCA) records.

Madhavi Majmudar and Yogin Majmudar serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230MH1997PTC111089

  • Company No.

    111089

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    06 Oct 1997

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Bakul Pharma Private Limited offer?

Bakul Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Chemical Intermediates, Formic Acid, Potassium Salts, Potassium Chloroplatinate.

Who are the key members and board of directors at Bakul Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Madhavi Majmudar Country flag representing In Director 16-Jan-1998Current
Yogin Majmudar Country flag representing In Director 06-Oct-1997Current

Financial Performance of Bakul Pharma.

Bakul Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.8% decrease. The company also saw a substantial improvement in profitability, with a 76.13% increase in profit. The company's net worth Soared by an impressive increase of 23.54%.

Bakul Pharma revenue growth over time
Bakul Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-0.80%
Revenue from Operations
-0.78%
Total Assets
-4.28%
Profit or Loss
76.13%
Net Worth
23.54%
EBITDA
89.95%

What is the Ownership and Shareholding Structure of Bakul Pharma?

In 2023, Bakul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹135.00 M

Satisfied Charges

₹330.80 M

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 12.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 1.50 Cr

Latest Charge Details

DateLenderAmountStatus
20 Oct 2021Hdfc Bank Limited₹5.50 CrOpen
29 Nov 2019The Hongkong And Shanghai Banking Corporation Limited₹1.50 CrOpen
12 Sep 2019Hdfc Bank Limited₹6.50 CrOpen
27 Feb 2019The Hongkong And Shanghai Banking Corporation Limited₹6.00 CrSatisfied
19 Jul 2018The Hongkong And Shanghai Banking Corporation Limited₹1.00 MSatisfied

How Many Employees Work at Bakul Pharma?

Bakul Pharma has a workforce of 92 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Bakul Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bakul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bakul Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bakul Pharma

Recent activity within the organization

  • Annual General Meeting

    Bakul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Bakul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 55.00 M registered on 20 Oct 2021 with Charge ID 100495954 was modified on 06 Mar 2023.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 55.00 M with Charge ID 100495954 was registered on 20 Oct 2021.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 65.00 M registered on 12 Sep 2019 with Charge ID 100289541 was modified on 24 Jun 2021.

  • Charges

    A charge registered on 27 Feb 2019 via Charge ID 100251125 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019.

Frequently asked questions

  • What is the Incorporation or founding date of Bakul Pharma Private Limited?

    Bakul Pharma Private Limited was incorporated on 06 Oct 1997.

  • What is authorized share capital and paid-up capital of Bakul Pharma Private Limited?

    The authorized share capital of Bakul Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.99 M.

  • Who are the current board members & directors of Bakul Pharma Private Limited?

    Currently 2 directors are associated with Bakul Pharma Private Limited.

    • Madhavi Yogin Majmudar
    • Yogin Ranjit Majmudar

  • What is the registered address of Bakul Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Bakul Pharma Private Limited is 16/2 Sterling Centre4Th Floor Dr A B Road Worli India, Mumbai, Maharashtra, 400018.

  • What is the corporate identification number (CIN) and company number of Bakul Pharma Private Limited?

    The corporate identification number (CIN) of Bakul Pharma Private Limited is U24230MH1997PTC111089 and the company number is 111089 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Bakul Pharma Private Limited?

    The Official website of Bakul Pharma Private Limited is https://www.bakulpharma.com

  • What has been the recent revenue trend for Bakul Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Bakul Pharma Private Limited has fallen by -0.80%.

  • How many employees does Bakul Pharma Private Limited currently have?

    As Per 2023 financial reports, 92 employees are currently employed by Bakul Pharma Private Limited.

  • What change has been observed in the net worth of Bakul Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Bakul Pharma Private Limited has experienced an upsurge of 23.54%.

  • What are the total open charges for Bakul Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Bakul Pharma Private Limited amount to ₹ 13.50 Cr.

  • When was the last Balance Sheet of Bakul Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Bakul Pharma Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed